CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Celecoxib

塞来昔布 杂质对照品Celecoxib Impurities

EPUSP60 个杂质条目60 impurity entries

本页汇总 塞来昔布 的 60 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 60 impurity reference standards of Celecoxib with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 塞来昔布(Celecoxib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesValidated green chromatographic methods for determination of amlodipine and celecoxib in presence of methylacetophenone
    Bioanalysis · 2021 · Z Sharkawi MM et al.  ·  PMID 34085866  ·  DOI
  2. 杂质研究Impurity studiesIsolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor
    Journal of pharmaceutical and biomedical analysis · 2004 · Satyanarayana U et al.  ·  PMID 15193741  ·  DOI
  3. 杂质研究Impurity studiesCytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
    Toxicology reports · 2020 · Reimann H et al.  ·  PMID 33304828  ·  DOI
  4. 分析方法Analytical MethodsDevelopment of a Unified Reversed-Phase HPLC Method for Efficient Determination of EP and USP Process-Related Impurities in Celecoxib Using Analytical Quality by Design Principles
    Molecules (Basel, Switzerland) · 2020 · Tome T et al.  ·  PMID 32069880  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisCopper-Catalyzed Reductive Ring-Cleavage of Isoxazoles: Synthesis of Fluoroalkylated Enaminones and Application for the Preparation of Celecoxib, Deracoxib, and Mavacoxib
    The Journal of organic chemistry · 2021 · Wan C et al.  ·  PMID 33586981  ·  DOI

塞来昔布 —— 原料药与杂质对照品Celecoxib — drug substance & impurities

共 61 个条目(含原料药本体)61 items incl. the drug substance
Celecoxib structure
EP原料药 APIAPI
塞来昔布Celecoxib
Celecoxib
CAS No.169590-42-5
Chemical FormulaC17H14F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 3 (Celecoxib EP Impurity A) structure
EPA
塞来昔布杂质3 (塞来昔布EP杂质A)Celecoxib Impurity 3 (Celecoxib EP Impurity A)
Celecoxib Impurity 3 (Celecoxib EP Impurity A)
CAS No.170570-01-1
Chemical FormulaC17H14F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 4 (Celecoxib EP Impurity B) structure
EPB
塞来昔布杂质4 (塞来昔布EP杂质B)Celecoxib Impurity 4 (Celecoxib EP Impurity B)
Celecoxib Impurity 4 (Celecoxib EP Impurity B)
CAS No.331943-04-5
Chemical FormulaC17H14F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 93 (Celecoxib USP Related Compound D) structure
USPD
塞来昔布杂质93 (塞来昔布USP相关化合物D)Celecoxib Impurity 93 (Celecoxib USP Related Compound D)
Celecoxib Impurity 93 (Celecoxib USP Related Compound D)
CAS No.3070439-43-6
Chemical FormulaC15H17N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 1 structure
1
塞来昔布杂质1Celecoxib Impurity 1
Celecoxib Impurity 1
CAS No.170569-99-0
Chemical FormulaC17H14F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 2 structure
2
塞来昔布杂质2Celecoxib Impurity 2
Celecoxib Impurity 2
CAS No.170571-01-4
Chemical FormulaC17H12F3N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
3
塞来昔布杂质3Celecoxib Impurity 3
Celecoxib Impurity 3
CAS No.170510-09-0
Chemical FormulaC18H19N3O2S
Purity>95%现货In stock
10mg25mg50mg100mg
Celecoxib Impurity 5 structure
5
塞来昔布杂质5Celecoxib Impurity 5
Celecoxib Impurity 5
CAS No.170571-00-3
Chemical FormulaC17H14F3N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 7 structure
7
塞来昔布杂质7Celecoxib Impurity 7
Celecoxib Impurity 7
CAS No.2629980-83-0
Chemical FormulaC17H16F3N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 8 structure
8
塞来昔布杂质8Celecoxib Impurity 8
Celecoxib Impurity 8
CAS No.219986-64-8
Chemical FormulaC11H9F3N2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 9 structure
9
塞来昔布杂质9Celecoxib Impurity 9
Celecoxib Impurity 9
CAS No.53764-99-1
Chemical FormulaC11H9F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 10 structure
10
塞来昔布杂质10Celecoxib Impurity 10
Celecoxib Impurity 10
CAS No.163266-02-2
Chemical FormulaC11H9F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 11 structure
11
塞来昔布杂质11Celecoxib Impurity 11
Celecoxib Impurity 11
CAS No.1061214-06-9
Chemical FormulaC15H17N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 13 structure
13
塞来昔布杂质13Celecoxib Impurity 13
Celecoxib Impurity 13
CAS No.170570-09-9
Chemical FormulaC18H16F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 16 structure
16
塞来昔布杂质16Celecoxib Impurity 16
Celecoxib Impurity 16
CAS No.915280-81-8
Chemical FormulaC8H8F3N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 18 structure
18
塞来昔布杂质18Celecoxib Impurity 18
Celecoxib Impurity 18
CAS No.1061214-09-2
Chemical FormulaC17H15F3N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 20 structure
20
塞来昔布杂质20Celecoxib Impurity 20
Celecoxib Impurity 20
CAS No.2356153-95-0
Chemical FormulaC17H14F3N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 22 structure
22
塞来昔布杂质22Celecoxib Impurity 22
Celecoxib Impurity 22
CAS No.921617-76-7
Chemical FormulaC17H13F3N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 23 structure
23
塞来昔布杂质23Celecoxib Impurity 23
Celecoxib Impurity 23
CAS No.720-94-5
Chemical FormulaC11H9F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 24 structure
24
塞来昔布杂质24Celecoxib Impurity 24
Celecoxib Impurity 24
CAS No.170569-87-6
Chemical FormulaC16H12F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 25 structure
25
塞来昔布杂质25Celecoxib Impurity 25
Celecoxib Impurity 25
CAS No.3064701-20-5
Chemical FormulaC17H14F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 29 structure
29
塞来昔布杂质29Celecoxib Impurity 29
Celecoxib Impurity 29
CAS No.2247197-65-3
Chemical FormulaC17H14F3N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 31 structure
31
塞来昔布杂质31Celecoxib Impurity 31
Celecoxib Impurity 31
CAS No.2247197-66-4
Chemical FormulaC18H15F3N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 32 structure
32
塞来昔布杂质32Celecoxib Impurity 32
Celecoxib Impurity 32
CAS No.2247197-67-5
Chemical FormulaC19H17F3N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 35 structure
35
塞来昔布杂质35Celecoxib Impurity 35
Celecoxib Impurity 35
CAS No.326-06-7
Chemical FormulaC10H7F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 36 Hydrochloride structure
36
塞来昔布杂质36 盐酸盐Celecoxib Impurity 36 Hydrochloride
Celecoxib Impurity 36 Hydrochloride
CAS No.17852-52-7
Chemical FormulaC6H9N3O2S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 36 structure
36
塞来昔布杂质36Celecoxib Impurity 36
Celecoxib Impurity 36
CAS No.4392-54-5
Chemical FormulaC6H9N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 40 structure
40
塞来昔布杂质40Celecoxib Impurity 40
Celecoxib Impurity 40
CAS No.343853-74-7
Chemical FormulaC6H7N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 42 structure
42
塞来昔布杂质42Celecoxib Impurity 42
Celecoxib Impurity 42
CAS No.457639-26-8
Chemical FormulaC18H16F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 44 structure
44
塞来昔布杂质44Celecoxib Impurity 44
Celecoxib Impurity 44
CAS No.1576-43-8
Chemical FormulaC6H7NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 47 structure
47
塞来昔布杂质47Celecoxib Impurity 47
Celecoxib Impurity 47
CAS No.6034-55-5
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 49 structure
49
塞来昔布杂质49Celecoxib Impurity 49
Celecoxib Impurity 49
CAS No.622-96-8
Chemical FormulaC9H12
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 50 structure
50
塞来昔布杂质50Celecoxib Impurity 50
Celecoxib Impurity 50
CAS No.585-74-0
Chemical FormulaC9H10O
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 51 structure
51
塞来昔布杂质51Celecoxib Impurity 51
Celecoxib Impurity 51
CAS No.24939-24-0
Chemical FormulaC6H6ClNO2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 52 structure
52
塞来昔布杂质52Celecoxib Impurity 52
Celecoxib Impurity 52
CAS No.1803258-57-2
Chemical FormulaC17H16F3N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 53 structure
53
塞来昔布杂质53Celecoxib Impurity 53
Celecoxib Impurity 53
CAS No.1189893-75-1
Chemical FormulaC18H14F3N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 54 structure
54
塞来昔布杂质54Celecoxib Impurity 54
Celecoxib Impurity 54
CAS No.170570-75-9
Chemical FormulaC17H13BrF3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 55 structure
55
塞来昔布杂质55Celecoxib Impurity 55
Celecoxib Impurity 55
CAS No.2055787-31-8
Chemical FormulaC17H12F3N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 56 structure
56
塞来昔布杂质56Celecoxib Impurity 56
Celecoxib Impurity 56
CAS No.198471-47-5
Chemical FormulaC19H16F3N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 57 structure
57
塞来昔布杂质57Celecoxib Impurity 57
Celecoxib Impurity 57
CAS No.94856-20-9
Chemical FormulaC12H11F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 58 structure
58
塞来昔布杂质58Celecoxib Impurity 58
Celecoxib Impurity 58
CAS No.569362-58-9
Chemical FormulaC18H16F3N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 59 structure
59
塞来昔布杂质59Celecoxib Impurity 59
Celecoxib Impurity 59
CAS No.4392-39-6
Chemical FormulaC12H13N5O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 60 structure
60
塞来昔布杂质60Celecoxib Impurity 60
Celecoxib Impurity 60
CAS No.2860553-66-6
Chemical FormulaC8H8N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 61 (N-Nitroso Celecoxib Impurity 36) structure
61
塞来昔布杂质61 (N-亚硝基塞来昔布杂质36)Celecoxib Impurity 61 (N-Nitroso Celecoxib Impurity 36)
Celecoxib Impurity 61 (N-Nitroso Celecoxib Impurity 36)
CAS No.2860553-70-2
Chemical FormulaC6H8N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 62 structure
62
塞来昔布杂质62Celecoxib Impurity 62
Celecoxib Impurity 62
CAS No.614-01-7
Chemical FormulaC6H7N3O
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 64 (N-Nitroso Aniline) structure
64
塞来昔布杂质64 (N-亚硝基苯胺)Celecoxib Impurity 64 (N-Nitroso Aniline)
Celecoxib Impurity 64 (N-Nitroso Aniline)
CAS No.36966-84-4
Chemical FormulaC6H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 66 structure
66
塞来昔布杂质66Celecoxib Impurity 66
Celecoxib Impurity 66
CAS No.64704-17-2
Chemical FormulaC11H15NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 67 structure
67
塞来昔布杂质67Celecoxib Impurity 67
Celecoxib Impurity 67
CAS No.98-64-6
Chemical FormulaC6H6ClNO2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 68 structure
68
塞来昔布杂质68Celecoxib Impurity 68
Celecoxib Impurity 68
CAS No.89-74-7
Chemical FormulaC10H12O
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 69 structure
69
塞来昔布杂质69Celecoxib Impurity 69
Celecoxib Impurity 69
CAS No.910303-54-7
Chemical FormulaC11H9F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 70 structure
70
塞来昔布杂质70Celecoxib Impurity 70
Celecoxib Impurity 70
CAS No.54779-81-6
Chemical FormulaC15H16N2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 73 structure
73
塞来昔布杂质73Celecoxib Impurity 73
Celecoxib Impurity 73
CAS No.36326-86-0
Chemical FormulaC6H6N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 75 structure
75
塞来昔布杂质75Celecoxib Impurity 75
Celecoxib Impurity 75
CAS No.877-67-8
Chemical FormulaC6H8N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 77 structure
77
塞来昔布杂质77Celecoxib Impurity 77
Celecoxib Impurity 77
CAS No.2860553-74-6
Chemical FormulaC15H16N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 78 structure
78
塞来昔布杂质78Celecoxib Impurity 78
Celecoxib Impurity 78
CAS No.876497-67-5
Chemical FormulaC6H5BrN2O
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 79 structure
79
塞来昔布杂质79Celecoxib Impurity 79
Celecoxib Impurity 79
CAS No.15847-87-7
Chemical FormulaC16H19N2O6P
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 81 structure
81
塞来昔布杂质81Celecoxib Impurity 81
Celecoxib Impurity 81
CAS No.90829-71-3
Chemical FormulaC6H7N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 82 structure
82
塞来昔布杂质82Celecoxib Impurity 82
Celecoxib Impurity 82
CAS No.2271123-54-5
Chemical FormulaC11H9F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 83 structure
83
塞来昔布杂质83Celecoxib Impurity 83
Celecoxib Impurity 83
CAS No.94856-19-6
Chemical FormulaC12H11F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 87 structure
87
塞来昔布杂质87Celecoxib Impurity 87
Celecoxib Impurity 87
CAS No.515845-18-8
Chemical FormulaC17H13F3N2
Purity>95%询价On request
10mg25mg50mg100mg
Celecoxib Impurity 92 structure
92
塞来昔布杂质92Celecoxib Impurity 92
Celecoxib Impurity 92
CAS No.2360-19-2
Chemical FormulaC6H7N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

塞来昔布 —— 研究文献与合成路线Celecoxib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 塞来昔布 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Celecoxib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability-indicating HPLC method for quantification of celecoxib and diacerein along with its impurities in capsule dosage form
    Bapatu HR, Maram RK, Murthy RS · Journal of chromatographic science · 2015 · 被引 7cited 7
  2. Celecoxib ameliorates diabetic sarcopenia by inhibiting inflammation, stress response, mitochondrial dysfunction, and subsequent activation of the protein degradation systems
    Deng C, Lu C, Wang K, et al. · Frontiers in pharmacology · 2024 · 被引 34cited 34
  3. A new stability--indicating RP-HPLC method to determine assay and known impurity of Celecoxib API
    Jadhav AS, Shingare MS · Drug development and industrial pharmacy · 2005 · 被引 6cited 6
  4. Development of a Unified Reversed-Phase HPLC Method for Efficient Determination of EP and USP Process-Related Impurities in Celecoxib Using Analytical Quality by Design Principles
    Tome T, Časar Z, Obreza A · Molecules (Basel, Switzerland) · 2020 · 被引 17cited 17
  5. Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation
    Venè R, Tosetti F, Minghelli S, et al. · Oncotarget · 2015 · 被引 15cited 15
  6. Five spectrophotometric methods for simultaneous determination of Amlodipine besylate and celecoxib in presence of its toxic impurity
    Sharkawi MMZ, Mohamed NR, El-Saadi MT, et al. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2021 · 被引 6cited 6

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR PREPARATION OF CELECOXIB CRYSTALLINE FORM
    MUPPIDI VAMSEE KRISHNA, RANGINENI SRINIVASULU, DUGGIRALA NAGA KIRAN, RAMAKRISHNAN SRIVIDYA, et al. · 公开号 US2011213159US2011213159 · 2011
  2. Process for preparation of celecoxib crystalline form
    MUPPIDI VAMSEE KRISHNA, RAGINENI SRINIVASULU, DUGGIRALA NAGA KIRAN, RAMAKRISHNAN SRIVIDYA, et al. · 公开号 EP2363395EP2363395 · 2011
  3. IMPROVED PROCESS FOR PREPARING CELECOXIB POLYMORPH
    CHARUGUNDLA KISHORE, RAO VENKATESWARA, KUMAR NEELA PRAVEEN, PRADHAN NITIN SHARADCHANDRA · 公开号 WO2011055233WO2011055233 · 2011
  4. AN IMPROVED PROCESS FOR THE PREPARATION OF CELECOXIB
    AMBATI V RAGHAVA REDDY, GARAGA SRINIVAS, MALLELA SAMBHU PRASAD SARMA, MEENAKSHISUNDERAM SIVAKUMARAN · 公开号 WO2010095024WO2010095024 · 2010
  5. STABLE AMORPHOUS CELECOXIB COMPOSITE AND PROCESS THEREFOR
    ZHUANG HONGCHUN, GAO PING · 公开号 JP2006321820JP2006321820 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

塞来昔布 杂质谱研究要点Celecoxib — impurity profiling notes

下面这些是拿到 塞来昔布 的 61 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 61 impurity entries for Celecoxib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances